1. Home
  2. RHI vs ADMA Comparison

RHI vs ADMA Comparison

Compare RHI & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robert Half Inc.

RHI

Robert Half Inc.

HOLD

Current Price

$30.82

Market Cap

2.8B

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$8.17

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RHI
ADMA
Founded
1948
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
RHI
ADMA
Price
$30.82
$8.17
Analyst Decision
Hold
Strong Buy
Analyst Count
7
4
Target Price
$30.33
$25.67
AVG Volume (30 Days)
1.8M
3.5M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
8.68%
N/A
EPS Growth
N/A
N/A
EPS
0.14
0.19
Revenue
$5,378,506,000.00
$42,219,783.00
Revenue This Year
$1.27
$27.46
Revenue Next Year
$5.95
$22.11
P/E Ratio
$221.07
$42.42
Revenue Growth
N/A
43.85
52 Week Low
$21.83
$7.21
52 Week High
$45.17
$22.37

Technical Indicators

Market Signals
Indicator
RHI
ADMA
Relative Strength Index (RSI) 63.52 42.40
Support Level $25.93 $7.38
Resistance Level $35.37 $16.61
Average True Range (ATR) 1.44 0.28
MACD 0.34 0.11
Stochastic Oscillator 82.35 57.28

Price Performance

Historical Comparison
RHI
ADMA

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: